Why Weight Comes Back After Dieting: It May Not Be About Willpower
Almost everyone who successfully loses weight faces the same frustrating problem: the pounds slowly return. Whether through dieting, exercise, or the increasingly popular GLP-1 medications such as semaglutide, weight often rebounds quickly once the intervention stops. For years, this has been misinterpreted as a lack of discipline, but a new study from Cleveland, Ohio, offers a different explanation.
Scientists from the Harrington Discovery Institute at University Hospitals and Case Western Reserve University have found that obesity creates a lasting biological change in fat cells that keeps the hunger hormone asprosin elevated even after weight loss. The researchers call this phenomenon "obesity memory."
What Is 'Obesity Memory'?
The team discovered that in obesity, an inflammatory signal called TGF-β1 rises, which in turn activates the production of asprosin. Asprosin is an appetite-stimulating hormone that signals the brain to eat.
Surprisingly, even after the TGF-β1 signal disappears and weight returns to normal, this "switch" in fat cells remains flipped on for weeks or longer. The study's senior author, Dr. Atul Chopra, investigator and associate director of the Harrington Rare Disease Program at Harrington Discovery Institute at UH, explained with an analogy:
- "It was like flipping a light switch that stays on even after you remove your finger."
- "Even after mice lost all the excess weight and TGF-β1 returned to normal, this switch in their fat cells remained flipped, keeping asprosin and appetite elevated."
This provides a molecular explanation for why GLP-1 drugs, which suppress appetite while you take them, cannot fix the underlying biological memory that drives hunger back up once treatment ends.
Obesity Risk May Pass From Mother to Child
The study also found that this signal can cross the placenta, programming a baby's fat cells before birth and giving the child a programmed susceptibility to obesity. This may explain why obesity tends to run in families and why diet and environment alone cannot account for this intergenerational transmission.
"This may also explain why obesity became such an epidemic, and why the cycle has continued for generations," said Dr. Chopra.
Blocking the Asprosin Pathway May Prevent Relapse
In mouse experiments, the researchers found that blocking the asprosin pathway—from the gene that produces it to the receptor in the brain that responds to it—prevented both weight regain after dieting and inherited obesity risk. This points to new therapeutic strategies.
Pharmaceutical companies are actively seeking ways to help people maintain weight loss after treatment. This study identifies a potential complementary target: a pathway that may sustain the biological drive toward regain after weight reduction.
The study was also reproduced by an independent laboratory. A separate lab led by Dr. Seth J. Field, chief scientific officer at the Harrington Discovery Institute at UH, reproduced the key persistence finding. Analyses of publicly available mouse and human datasets also yielded supporting evidence.
What This Means for Clinicians and Patients
Dr. Chopra emphasized that obesity relapse is not a failure of willpower or discipline. It is driven by a durable biological memory written into fat tissue.
- "We need to treat obesity as a condition that leaves lasting biological scars, not just a temporary state of excess weight."
- "This explains why patients on GLP-1 medications regain weight when they discontinue the drugs. The medication suppresses appetite temporarily but does not erase the epigenetic memory in fat cells."
The critical next step is translating the findings into humans. The researchers plan to confirm that the same epigenetic memory operates in human fat tissue after weight loss and to test whether therapies that block asprosin or reset these epigenetic marks can prevent weight regain in people.
"Given the need for durable obesity treatments, we are interested in whether asprosin-blocking therapies could be used alongside or after GLP-1 treatment to prevent rebound," concluded Dr. Chopra.
Practical Tips for Daily Health Management
While this research is still in its early stages, it reminds us that weight management is a complex biological process, not simply a matter of "eating less and moving more." For those who are losing weight or using GLP-1 medications, consider the following:
- Work with your doctor to develop a long-term weight management plan rather than pursuing rapid short-term weight loss.
- After stopping medication, monitor your weight and metabolic indicators regularly to detect rebound trends early.
- Pay attention to changes in appetite and seek professional medical support when needed.
- Maintain a regular sleep schedule and moderate exercise to support overall metabolic health.
Want to better track your weight, appetite, and metabolic changes? The Xiaoshu Health App can sync with Apple Health to track relevant indicators, helping you understand your body more scientifically and providing data support for long-term health management.